George Somlo, MD, medical oncologist, City of Hope, discusses recent advancements in multiple myeloma treatment.
SunRISE Program Incites Optimism About the Future of High-Risk, BCG-Unresponsive NMIBC Treatment
May 24th 2023In an interview with Targeted Oncology, Siamak Daneshmand, MD, discussed TAR-200 as seen in the SunRISE-1 trial and the what is up next for the treatment landscape of high-risk BCG-unresponsive non-muscle invasive bladder cancer.
Read More
2 Clarke Drive
Cranbury, NJ 08512